Actively Recruiting
Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease
Led by Centre Hospitalier Universitaire de Nice · Updated on 2025-07-10
60
Participants Needed
1
Research Sites
130 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigator aim to identify the role of inorganic pyrophosphate and other anti-calcifying molecules in vascular disease in children with chronic kidney disease, with a view to developing therapeutic approaches aimed at limiting the onset of vasculopathy.
CONDITIONS
Official Title
Inorganic Pyrophosphate Homeostasis (PPi) in Pediatric Chronic Kidney Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Minor patients (<18 years)
- Patients of both sexes
- Informed patients and parents who have signed the informed consent form
- Patients affiliated to social security
- Control group patients have no particular pathology and are undergoing surgery with a preoperative check-up
- Patients on dialysis for more than 3 months, regardless of technique
- Kidney transplant patients
- Patients with chronic kidney disease regardless of cause
You will not qualify if you...
- Progressive cancer or kidney disease
- Treatments that may modify pyrophosphate concentration (e.g., bisphosphonates)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
CHU Nice - Hôpital de l'Archet 2
Nice, Alpes-Maritimes, France, 06200
Actively Recruiting
Research Team
J
Julie BERNARDOR
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here